Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide

Diabetes Care

Volumn 31, Issue 12, 2008, Pages 2325-2331

  Woerle, Hans J ^a   Albrecht, Max ^a   Linke, Rainer ^a   Zschau, Silvia ^b   Neumann, Christoph ^b   Nicolaus, Mathias ^a   Gerich, John E ^c   Göke, Burkhard ^a   Schirra, Joerg ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Outpatient Diabetes Center   (Germany)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; GLUCOSE; INSULIN; PLACEBO; PRAMLINTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INGESTION; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE ANALYSIS; MALE; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; SINGLE BLIND PROCEDURE; SPLANCHNIC BLOOD FLOW; STOMACH CONTENT; STOMACH EMPTYING; TREATMENT DURATION;

ADULT; AMYLOID; DIABETES MELLITUS, TYPE 1; FEMALE; GASTRIC EMPTYING; HUMANS; HYPERGLYCEMIA; MALE;

EID: 64349110518     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2446     Document Type: Article

References (28)

1. Woerle HJ, Szoke E, Meyer C, DostouJM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE: Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 290:E67-E77, 2006
2. Horowitz M, Edelbroek MA, Wishart JM, Straathof JW: Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36: 857-862, 1993
3. Frank JW, Saslow SB, Camilleri M, Thom- forde GM, Dinneen S, Rizza RA: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 109:755-765, 1995
4. Stacher G: Diabetes mellitus and the stomach. Diabetologia 44:1080-1093, 2001
5. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M: Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19:177-194, 2002
6. Camilleri M: Clinical practice: ;Diabetic gastroparesis. NEngl JMed 356:820-829, 2007
7. Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J: Hypergly- caemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:675-680, 1990
8. Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich JE, Goke B, Schirra J: Importance of changes in gastric emptying for postprandial plasma glucose excursions in healthy humans. Am J Physiol Endocrinol Metab 294: E103-E109, 2008
9. Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C: Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin- dependent diabetes mellitus. Gastroenter- ology 113:60 -66, 1997
10. Fehmann HC, Weber V, Goke R, Goke B, Arnold R: Cosecretion of amylin and in sulin from isolated rat pancreas. FEBS Lett 262:279-281, 1990
11. Schmitz O, Brock B, Rungby J: Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 53 (Suppl. 3): S233-S238, 2004
12. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
13. Kong MF, Stubbs TA, King P, Macdonald IA, Lambourne JE, Blackshaw PE, Perkins AC, Tattersall RB: The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabeto- logia 41:577-583, 1998
14. Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, Moyses C, Tattersall RB: Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia 40:82-88, 1997
15. Mokan M, Gerich J: A simple insulin infusion algorithm for establishing and maintaining overnight near-normoglyce- mia in type I and type II diabetes. J Clin Endocrinol Metab 74:943-945, 1992
16. Fritsche A, Stefan N, Hardt E, Haring H, Stumvoll M: Characterisation of (β-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin- induced insulin secretion. Diabetologia 43:852-858, 2000
17. Woerle HJ, Mariuz PR, Meyer C, Reich- man RC, Popa EM, Dostou JM, Welle SL, Gerich JE: Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 52:918-925, 2003
18. Young A: Inhibition of gastric emptying. Adv Pharmacol 52:99-121, 2005
19. Kong M, King P, Macdonald I, Blackshaw P, Perkins A, Armstrong E, Buchanan K, Tattersall R: Effect of euglycaemic hyper- insulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects. Diabetologia 41:474-481, 1998
20. Kong MF, King P, Macdonald IA, Black- shaw PE, Horowitz M, Perkins AC, Armstrong E, Buchanan KD, Tattersall RB: Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus. Diabetologia 42:365372, 1999.
21. Chaikomin R, Rayner CK, Jones KL, Horowitz M: Upper gastrointestinal function and glycemic control in diabetes mel- litus. World J Gastroenterol l2:56ll- 5621, 2006
22. Schirra J, Leicht P, Hildebrand P, Beg- linger C, Arnold R, Goke B, Katschinski M: Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide- l(7-36)amide in non-insulin dependent diabetes mellitus. J Endocrinol 156:177186, 1998
23. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B: Gastric emptying and release of incretin hormones after glucose ingestion in humans 13. J Clin Invest 97:92-103, 1996
24. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA: Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol 278:G946-G95l, 2000
25. Fehmann HC, Weber V, Goke R, Goke B, Eissele R, Arnold R: Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem Biophys Res Commun 167: 1102-1108, 1990
26. Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR: Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type l diabetes intensively treated with insulin pumps. Diabetes Care 26:1-8, 2003
27. Gerich JE: Clinical significance, patho- genesis, and management of postprandial hyperglycemia. Arch Intern Med 163: 1306-1316, 2003
28. l3C nuclear magnetic resonance spectroscopy study. J Clin Invest 95: 783-787, 1995